Skip to content
TrialScanner

NCT01308294

Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients

Phase 1/Phase 2TerminatedIMMPCollaborator

Registry record

Lead sponsor
Centre Hospitalier Universitaire Vaudois
Conditions
Melanoma
Primary completion
Apr 2014Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01308294 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01308294: Immunotherapy of HLA-A2... | TrialScanner